3rd Quarter - Report — PFIZER INC. for PFIZER INC. (2014)

Firm

PFIZER INC.

Client

PFIZER INC.

Income

—

Expenses

$2,200,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
3rd Quarter - Report	Oct 20, 2014	$2,100,000	Replaced
3rd Quarter - Report (this page)	Feb 3, 2015	$2,200,000	Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP Taiwan Pricing Issues Thailand Pricing Issues Egypt Pricing Issues Algeria Pricing Issues Venezuela Pricing Issues

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
DOUGLAS REID GOUDIE	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Treasury, Dept of; Commerce, Dept of (DOC); Natl Security Council (NSC); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); State, Dept of (DOS)

Taxation/Internal Revenue Code TAX

Deferral Comprehensive Tax Reform Territorial Systems BudgetBase Erosion and Profit Shifting (BEPS)

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
CAROLINE MOODY SCHELLHAS	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); U.S. Trade Representative (USTR); Natl Security Council (NSC); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Treasury, Dept of; State, Dept of (DOS)

Copyright/Patent/Trademark CPT

Patent Settlements Patent Troll Legislation Preventing Abuse of Cough Treatment Act

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—

Contacted: Treasury, Dept of; Natl Security Council (NSC); Patent & Trademark Office (PTO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Commerce, Dept of (DOC)

Health Issues HCR

Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations 340B

Lobbyist	Covered position, as disclosed
PAULA BURG	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Treasury, Dept of; Natl Security Council (NSC); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: Treasury, Dept of; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Consumer Issues/Safety/Products CSP

Designer Anabolic Steroid Act

Lobbyist	Covered position, as disclosed
ANGELA WALKER RIEMER	—

Contacted: Patent & Trademark Office (PTO); Treasury, Dept of; SENATE; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Security Council (NSC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.